Back to top

Weakness Seen in Synta Pharmaceuticals (SNTA): Stock Tumbles 13.5%
March 06, 2014

Read MoreHide Full Article
Synta Pharmaceuticals Corp. saw a big move last session, as the company’s shares fell more than 13% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for SNTA as the stock is now up around 8.4% in the past one-month time frame.

The company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks. There has been no estimate revision on either side, and the consensus for loss estimates has widened marginally. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

SNTA currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare sector include Alexion Pharmaceuticals, Inc. (ALXN - Free Report) , Alkermes plc (ALKS - Free Report) and Emergent BioSolutions, Inc. (EBS - Free Report) . All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alexion Pharmaceuticals, Inc. (ALXN) - free report >>

Alkermes PLC (ALKS) - free report >>

Emergent Biosolutions, Inc. (EBS) - free report >>

More from Zacks Tale of the Tape

You May Like